Bank of Nova Scotia Lowers Holdings in The Clorox Company $CLX
Bank of Nova Scotia reduced its position in The Clorox Company (NYSE:CLX - Free Report) by 88. 7% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 19,118 shares of the company's stock after selling 150,515 shares during the quarter. Bank of Nova Scotia's holdi
Bank of Nova Scotia reduced its position in The Clorox Company (NYSE:CLX-Free Report) by 88. 7% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 19,118 shares of the company's stock after selling 150,515 shares during the quarter. Bank of Nova Scotia's holdings in Clorox were worth $1,981,000 as of its most recent filing with the SEC. 5 High-Yield Stocks That Could Help Cushion Market VolatilitySeveral other hedge funds also recently made changes to their positions in CLX. Wilkins Investment Counsel Inc. boosted its stake in Clorox by 250. 6% in the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company's stock valued at $5,552,000 after acquiring an additional 39,360 shares in the last quarter. Morningstar Investment Management LLC increased its position in shares of Clorox by 131. 8% during the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company's stock worth $6,297,000 after purchasing an additional 35,506 shares in the last quarter. National Pension Service lifted its holdings in shares of Clorox by 68. 9% during the 4th quarter. National Pension Service now owns 27,537 shares of the company's stock valued at $2,777,000 after purchasing an additional 11,233 shares during the last quarter. Birch Hill Investment Advisors LLC purchased a new stake in shares of Clorox during the 4th quarter valued at $22,103,000. Finally, Ilmarinen Mutual Pension Insurance Co acquired a new stake in shares of Clorox in the 4th quarter worth $1,966,000. Institutional investors and hedge funds own 78. 53% of the company's stock. GetCloroxalerts:Insider Buying and SellingIn other news, DirectorPierre R. Breberpurchased 5,000 shares of the firm's stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85. 82 per share, for a total transaction of $429,100. 00. Following the completion of the purchase, the director directly owned 18,000 shares of the company's stock, valued at approximately $1,544,760. This trade represents a 38. 46% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available atthis link. 0. 63% of the stock is owned by company insiders. Clorox Stock Performance3 Defensive Stocks to Buy as Economic Uncertainty LingersNYSE CLXopened at $99. 67 on Thursday. The stock has a fifty day simple moving average of $95. 46 and a 200-day simple moving average of $103. 79. The Clorox Company has a twelve month low of $84. 70 and a twelve month high of $128. 90. The company has a current ratio of 0. 84, a quick ratio of 0. 65 and a debt-to-equity ratio of 27. 03. The stock has a market cap of $12. 05 billion, a PE ratio of 16. 18 and a beta of 0. 54. Clorox (NYSE:CLX-Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $1. 64 earnings per share for the quarter, topping the consensus estimate of $1. 55 by $0. 09. Clorox had a net margin of 11. 18% and a return on equity of 443. 64%. The company had revenue of $1. 67 billion during the quarter, compared to analyst estimates of $1. 67 billion. During the same quarter last year, the firm posted $1. 45 earnings per share. Clorox's revenue was up . 1% compared to the same quarter last year. Equities analysts anticipate that The Clorox Company will post 5. 52 earnings per share for the current year. Wall Street Analyst Weigh In3 Dividend Stocks Raising Payouts—and Backing It Up With ResultsA number of equities research analysts have commented on CLX shares. Barclays raised their price target on Clorox from $85. 00 to $86. 00 and gave the stock an "underweight" rating in a report on Tuesday, July 21st. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $94. 00 price objective on shares of Clorox in a report on Wednesday, July 22nd. Citigroup decreased their price objective on shares of Clorox from $110. 00 to $97. 00 and set a "neutral" rating for the company in a research report on Friday, May 1st. Wells Fargo & Company lowered their target price on shares of Clorox from $100. 00 to $95. 00 and set an "equal weight" rating for the company in a research note on Monday, May 18th. Finally, Evercore reissued an "underperform" rating and set a $98. 00 target price on shares of Clorox in a research report on Thursday, July 23rd. Twelve investment analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company's stock. Based on data from MarketBeat. com, the stock presently has a consensus rating of "Reduce" and an average target price of $101. 00. Check Out Our Latest Stock Analysis on CLXClorox Company Profile(Free Report)The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses. Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines. Featured StoriesFive stocks we like better than CloroxWhy SK hynix Could Be the Best AI Chip Stock to Buy NowSeagate Technology Stock Surges as Earnings Beat Silences AI DoubtersAlphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?Why Bloom Energy May Be the Most Important AI Infrastructure StockWant to see what other hedge funds are holding CLX?Visit HoldingsChannel. comto get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX-Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Should You Invest $1,000 in Clorox Right Now?Before you consider Clorox, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Clorox wasn't on the list. While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list. Get This Free Report